Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P130026/S096

TactiCath Contact Force Ablation Catheter, Sensor Enabled

St Jude Medical · Decision date Dec 23, 2025

FDA DECISIONP130026/S096

What did the FDA approve?

FDA records P130026/S096 as a supplement to PMA P130026, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Dec 23, 2025.

FDA approval order statement

Approval for consolidating the integrated cabling of the existing TactiCath SE ablation catheters and introducing a non-sterile, reusable cable in place of the current design.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Dec 23, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P130026/S096
Regulatory pathway
PMA supplement
Product code
OAE
Decision code
APPR
Decision date
Dec 23, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.

Product code
OAE
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P130026/S096 received

    Application receipt date recorded by FDA.

  2. P130026/S096 · FDA decision

    Real-Time Process

  3. P130026/S097 · Related supplement

    TactiCath Contact Force Ablation Catheter, Sensor Enabled (TactiCath SE)

  4. P130026/S098 · Related supplement

    TactiCath Sensor Enabled

  5. P130026/S099 · Related supplement

    TactiCath CF Ablation Catheter, Sensor Enabled (A-TCSE-D; A-TCSE-F; A-TCSE-J; A-TCSE-DD; A-TCSE-DF; A-TCSE-FF; A-TCSE-

  6. P130026/S101 · Related supplement

    TactiCath Ablation Catheter, Sensor Enabled (TactiCath SE)

  7. P130026/S100 · Related supplement

    TactiCath Contact Force Ablation Catheter, Sensor Enabled

  8. P130026/S102 · Related supplement

    TactiSys Quartz Equipment; Ampere Generator

Timeline entries are records held by MedtechLedger for P130026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P130026

Explore the linked device profile

Other records with product code OAE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

St Jude Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One St. Jude Medical Dr., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records